SHELTON, CT / ACCESS Newswire / October 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...
(NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, herewith provides additional details on its Phase II Clinical Trial of NV-387 Oral ...
With an epidemic, the slower the response, the bigger it grows,” said Julien Harneis, a senior Ebola response coordinator for ...
When I was told I had Ebola, I already felt like a dead man,” recalls Jean Vianney, 44, who has now recovered from the ...
NanoViricides, Inc. provided additional details on its Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus (BDBV) and other Ebola viruses in the ...
"Grace has been shown to us," sing health workers at the epicentre of DR Congo's Ebola outbreak It is strange to witness singing and dancing in a place which has seen so much death but the successful ...
GENEVA: The World Health Organization on Friday announced the first recovery of a confirmed Ebola patient in the outbreak raging in the Democratic Republic of Congo. "The DRC has said that on May 27, ...
For years, Alex Olela fought Ebola on the front lines, treating patients during five outbreaks of the deadly disease in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results